| The burden of opioid-related mortality in the United States T Gomes, M Tadrous, MM Mamdani, JM Paterson, DN Juurlink JAMA network open 1 (2), e180217-e180217, 2018 | 616 | 2018 |
| Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario S Nasreen, H Chung, S He, KA Brown, JB Gubbay, SA Buchan, DB Fell, ... Nature microbiology 7 (3), 379-385, 2022 | 462 | 2022 |
| Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study H Chung, S He, S Nasreen, ME Sundaram, SA Buchan, SE Wilson, ... bmj 374, 2021 | 355 | 2021 |
| Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes SA Buchan, H Chung, KA Brown, PC Austin, DB Fell, JB Gubbay, ... JAMA network open 5 (9), e2232760-e2232760, 2022 | 348 | 2022 |
| Virtual care use before and during the COVID-19 pandemic: a repeated cross-sectional study RS Bhatia, C Chu, A Pang, M Tadrous, V Stamenova, P Cram Canadian Medical Association Open Access Journal 9 (1), E107-E114, 2021 | 225 | 2021 |
| Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada T Gomes, W Khuu, D Martins, M Tadrous, MM Mamdani, JM Paterson, ... bmj 362, 2018 | 175 | 2018 |
| Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials MA Amiche, JM Albaum, M Tadrous, P Pechlivanoglou, LE Lévesque, ... Osteoporosis International 27, 1709-1718, 2016 | 161 | 2016 |
| Rural telemedicine use before and during the COVID-19 pandemic: repeated cross-sectional study C Chu, P Cram, A Pang, V Stamenova, M Tadrous, RS Bhatia Journal of medical Internet research 23 (4), e26960, 2021 | 160 | 2021 |
| Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: a population-based retrospective cohort study AA Verma, W Khuu, M Tadrous, T Gomes, MM Mamdani PLoS medicine 15 (6), e1002584, 2018 | 129 | 2018 |
| “Like being put on an ice floe and shoved away”: a qualitative study of the impacts of opioid-related policy changes on people who take opioids T Antoniou, K Ala-Leppilampi, D Shearer, JA Parsons, M Tadrous, ... International Journal of Drug Policy 66, 15-22, 2019 | 111 | 2019 |
| Comparison of medication prescribing before and after the COVID-19 pandemic among nursing home residents in Ontario, Canada MA Campitelli, SE Bronskill, LC Maclagan, DA Harris, CA Cotton, ... JAMA Network Open 4 (8), e2118441-e2118441, 2021 | 104 | 2021 |
| Antipsychotic use with and without comorbid psychiatric diagnosis among adults with intellectual and developmental disabilities Y Lunsky, W Khuu, M Tadrous, S Vigod, V Cobigo, T Gomes The Canadian Journal of Psychiatry 63 (6), 361-369, 2018 | 94 | 2018 |
| Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials PD Meek, SD Evang, M Tadrous, D Roux-Lirange, DM Triller, B Gumustop Digestive diseases and sciences 56, 7-18, 2011 | 93 | 2011 |
| Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study SV Pasricha, M Tadrous, W Khuu, DN Juurlink, MM Mamdani, ... Pain 159 (8), 1562-1568, 2018 | 86 | 2018 |
| Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation T Gomes, TJ Campbell, SA Kitchen, R Garg, N Bozinoff, S Men, ... Jama 327 (9), 846-855, 2022 | 74 | 2022 |
| Population-based evaluation of the effectiveness of nirmatrelvir–ritonavir for reducing hospital admissions and mortality from COVID-19 KL Schwartz, J Wang, M Tadrous, BJ Langford, N Daneman, V Leung, ... Cmaj 195 (6), E220-E226, 2023 | 71 | 2023 |
| Thimerosal-containing vaccines and autism: a review of recent epidemiologic studies AM Hurley, M Tadrous, ES Miller The Journal of Pediatric Pharmacology and Therapeutics 15 (3), 173-181, 2010 | 71 | 2010 |
| Disease risk score as a confounder summary method: systematic review and recommendations M Tadrous, JJ Gagne, T Stürmer, SM Cadarette Pharmacoepidemiology and drug safety 22 (2), 122-129, 2013 | 70 | 2013 |
| National trends in prescription drug expenditures and projections for 2022 EM Tichy, JM Hoffman, KJ Suda, MH Rim, M Tadrous, S Cuellar, JS Clark, ... American Journal of Health-System Pharmacy 79 (14), 1158-1172, 2022 | 62 | 2022 |
| Measuring the burden of opioid-related mortality in Ontario, Canada T Gomes, S Greaves, M Tadrous, MM Mamdani, JM Paterson, DN Juurlink Journal of addiction medicine 12 (5), 418-419, 2018 | 62 | 2018 |
David JuurlinkClinical Pharmacology and Toxicology, University of TorontoVerified email at ices.on.ca
